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Abstract
Toxoplasmosis is a parasitic zoonotic disease widely distributed worldwide
and is caused by the intracellular parasite Toxoplasma gondii. The definitive
host of T. gondii is the domestic cat and the entire cat family, in which the sexu‐
al stages of the parasite develop. T. gondii can also infect a wide range of inter‐
mediate hosts, affecting most warm-blooded animals including humans. In
humans, toxoplasmosis is usually asymptomatic in healthy individuals, but
can develop lymphadenopathy and nonspecific symptomatology or even be
fatal in infants with congenital toxoplasmosis and in immunocompromised pa‐
tients. Transmission to humans is mainly through food, especially by eating
undercooked meat or meat contaminated with tissue cysts. This has led to vari‐
ous public health organizations worldwide monitoring programs on T. gondii
in animals intended for human consumption, especially in meat samples. One
of the techniques employed in the laboratory is that based on the polymerase
chain reaction and some of its variants, which have proven to be valuable tools
for the detection of T. gondii in tissues for human consumption and many other
types of biological samples. The development of different strategies for the mo‐
lecular detection of T. gondii has led to the identification and quantification
methodologies varying widely among laboratories. Therefore, this chapter re‐
views the main methods of extraction, purification, detection and quantifica‐
tion of T. gondii DNA in tissue samples from different species destined for
human consumption.
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1. Introduction
Toxoplasmosis is a zoonotic disease widely distributed throughout the world and is caused
by the intracellular parasite Toxoplasma gondii. The definitive host of the parasite is the domestic
cat and the entire cat family, in which the parasite reproduces sexually. T. gondii can also infect
a wide range of intermediate hosts, affecting most warm-blooded animals [1].
In humans, toxoplasmosis is usually asymptomatic in healthy individuals, but can develop
lymphadenopathy and nonspecific symptomatology or even be fatal in infants with congenital
toxoplasmosis (CT) and in immunocompromised patients (such as people with AIDS), in
persons with problems in bone marrow and recipient patients of transplanted organs) [2].
Toxoplasmosis transmission to humans is mainly through food and from exposure to different
stages of T. gondii, particularly by ingestion of sporulated oocysts found in the environment
and contaminated water and food, or by ingestion of tissue cysts or tachyzoites contained in
meat and products derived from the meat of various animals, [1,3,4].
The consumption of undercooked, raw or cured meat is a major mode of transmission of
Toxoplasmosis to humans, especially in cases of CT, which has been attributed to 30% to 60%
of cases of infection during pregnancy [5]. This has led to various public health organizations
worldwide monitoring programs introduced on T. gondii in animals intended for human
consumption, mainly in meat samples [6].
2. Occurrence of toxoplasmosis
T. gondii is a parasite that is widely distributed around the world, showing a higher incidence
in tropical areas and a decrease when the latitude increases [7]. The estimated prevalence in
the human population varies widely in different geographical areas, between different cities
within the same city and between different ethnic groups even when they live in the same area
[6,8]. In humans, toxoplasmosis is considered the third leading cause of death among food‐
borne diseases [7].
As well in humans, T. gondii is widely distributed worldwide. Parasite presence has been
described in several animal species (wild, companion and production animals). However,
food-producing animals may represent a real risk for transmission of the disease to humans,
either directly or through farming [9]. Several serological assays have been performed in free-
ranging chickens, because the information provided is usually used as an index of environ‐
mental contamination with oocysts [10]. Prevalence rates in these animals in Central and South
America ranges from 40 to 60% [11],and other reports from India describe prevalence rates
from 20 to 40% [12,13]; in Egypt there are rates reported around 40% [10,14] and in China,
30.36% [15]. Pigs and sheep are also commonly infected. Pigs are very susceptible to become
experimentally infected and show high prevalence rates in some regions of the United States,
as well in warm and tropical countries [16–21]. Prevalence rates of T. gondii in sheep are also
widely distributed. For example in the United States, there has been described prevalence rate
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in range of 27 to 73 %; Uruguay, Argentina, Chile, Mexico and the United Kingdom showed
prevalence rates of around 30%, but there are some countries with higher rates such as Ivory
Coast, France and Turkey, where prevalence rates of 68, 89 and 95.7%, respectively, have been
reported [22]. Cattle and buffaloes are not considered as probably sources of significant
infection [22] as cows are relatively resistant to experimental infection [24].
In general, the occurrence infection by T. gondii in animals varies depending on weather
conditions, geographical area, type of species, either productive or wild, as well as the age of
the animals, the type of farming system (extensive, semi-extensive, intensive), the management
and the existence of health programs [22,25,26]. Also, there have been described many factors
that have an important impact on foodborne transmission of T. gondii to humans, such as the
type of management and production of livestock, hygienic standards of slaughterhouses, food
processing and technology, the density of cats or wild felines in the area and climate change,
which may influence the sporulation of oocysts in the environment (i.e., temperature, humid‐
ity, wind) [6].
3. Clinical signs in animals and humans
3.1. Toxoplasmosis in humans
The clinical spectrum of the disease varies widely and depends primarily on the immune status
of the host and Toxoplasma lineage to which a person was exposed. In humans, toxoplasmosis
may manifest basically in five ways: asymptomatic, acute infection, congenital, ocular and the
immunocompromised patient. In immunocompetent persons toxoplasmosis is usually
asymptomatic or develops mild symptoms that go unnoticed in 80–90% of cases [27]. The usual
clinical manifestations, trend to be laterocervical lymphadenopathy which is often treated, less
frequently supraclavicular nodes, occipital, inguinal, mediastinal lymph node or any other
chain are affected; patients with lymphadenopathy also have other symptoms such as fever,
malaise, arthralgia, asthenia, night sweats, sore throat or maculopapular rash, no itching,
which usually spares the palms and soles. The clinical picture of acute toxoplasmosis is usually
benign and self-limiting; in <1 month, progression to the severe form is rare in immunocom‐
petent hosts [27–30]. In immunocompromised subjects, acute toxoplasmosis usually occurs
widely where the main sites of spread are the central nervous system, eyes, heart, liver and
lungs, with preference in the tissues where the immune response is limited, causing injuries.
In immunocompromised patients, such as AIDS patients with very low CD4 counts, patients
under immunosuppression to prevent or treat transplant rejection and fetuses, a reactivation
of an earlier infection, rather than a newly acquired one, is common. In these individuals the
parasite can induce besides encephalitis and retinochoroiditis, carditis, pneumonia, and
meningitis, among other manifestations [31]. Ocular toxoplasmosis is produced in most cases
by breaking tissue cysts that are congenitally acquired; however, it can occur in acquired
infections too. It manifests as uveitis or retinochoroiditis with exudate and decreased vision;
the lesion can be observed by fundus evaluation. The ocular presentation is commonly
characterized by necrotic lesions destroying retinal architecture, sometimes engaging and
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choroid (retinochoroiditis) [28,30]. CT is the most significant complication of active infection.
When the infection is acquired during pregnancy, either by reactivation of latent-phase
bradyzoites or by a primary infection, the parasites migrate to the placenta and from there to
the fetus. The severity of the disease depends on the stage of pregnancy when the parasites
cross the placenta. At the beginning of pregnancy, fetal infection is rare, but when it happens,
it triggers severe injury or death of the fetus. As the pregnancy progresses, congenital infection
is most common, but the damage tends to be lower [29,32]. When the disease occurs in utero,
there may be consequences observed at birth. Most congenital infections are asymptomatic,
although in some cases the child is born with acute illness, where cases of hydrocephalus, eye
damage and visceral can be found. In other cases, the disease develops after birth or become
dormant for a long time [29,32].
3.2. Toxoplasmosis in animals
Natural infection in non-pregnant animals usually elapses without symptoms, but primary
infection during pregnancy can cause embryonic death, abortion, birth weak or clinically
normal but infected animals. Globally, T. gondii is the cause of 11–14% of the abortions that
occur in sheep and goats [33]. In cattle, by contrast, T. gondii infection is not considered a
common cause of abortion and presented asymptomatic. T. gondii in dogs is considered an
opportunistic pathogen and infection is usually subclinical, but under certain conditions
clinical signs are present, predominantly respiratory and neuromuscular manifestations
(Dubey, 2010). Cats even as definitive hosts usually enrolled asymptomatic infection, even
during removal of oocysts; however, sometimes clinical signs are present, primarily associated
with respiratory type interstitial pneumonia, dyspnea, lethargy and anorexia, ocular signs
(uveitis, retinochoroiditis) or neuromuscular signs [34]. In cats it has also been described as
intrauterine infection; thus, infected animals generally have more severe signs: encephalitis,
hepatitis, ascites, respiratory signs and perinatal death or weaning [35]. In the pigs, the disease
usually attends in subclinical and can be seen in some cases of weak animals born or stillborn;
in adult animals weight loss, anorexia and fever have been observed, which usually disappear
by the third week after infection regardless of variant of T. gondii. Pigs are considered an
important source of infection for humans because of the high parasite loads encountered in
their tissues compared to other productive animals [22,35].
4. Economic impact of toxoplasmosis
The real economic impact of toxoplasmosis is difficult to estimate, because in most immuno‐
competent individuals, the infection goes unnoticed or has claimed clinical presentation to
other diseases [22,29]. However, it is estimated that the economic impact should be very high
due to the loss of one or more days of work in mild cases, treatment and care needs, sick
children, especially those with mental retardation and blindness, loss of quality lifestyle and
the costs of hospitalization in severe cases and the cost of monitoring pregnant women and
treatment during pregnancy who are T. gondii positive [26,36,37].
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In United States,, despite the low incidence, the economic impact of CT is high due to the
severity of the infection, associated complications, treatment and social costs. CT costs have
been estimated as $ 1.26 million per case and were mainly attributed to drug costs, annual
losses of productivity, special education and health care costs [38]. On the other hand, in the
United States, some 3,000 babies are born every year with CT and the annual cost of treating
this disease is between US$ 31 and US$ 40 million [39]. The total economic impact of CT just
in the United States has been estimated as over $ 7.7 billion per year, which makes it the second
most important infection to humans after foodborne salmonellosis [40]. In the United King‐
dom, the annual economic impact is estimated $ 12 million [26].
In most productive animals, toxoplasmosis occurs asymptomatically; however, in animal
production, toxoplasmosis is considered as an economically important disease of livestock,
especially sheep and goats, where it can cause early embryonic death and resorption, fetal
death and mummification, abortion, stillbirth and neonatal death [41].
Regarding economic impact of infection with T. gondii in productive species, just in the United
Kingdom, economic losses were estimated to be between 15 and 20%, from scanning to sale,
but on some farms losses can reach over 30% [42]. This is often a result of a disease outbreak
of T. gondii abortion. Other authors had mentioned that cost of Toxoplasma in the UK flock was
estimated to be £12 million [43]. These estimates included loss of production, cost of treatment,
control and monitoring but did not include the costs associated with human health. As a matter
of fact, the economic losses caused by T. gondii infection in sheep are difficult to estimate
because the disease occurs sporadically. Moreover, only a small number of the lambs aborted
are subjected to diagnosis [43]. In addition, the material sent for diagnosis, besides being
potentially inadequate, might also be examined erroneously and, finally, serological testing
lacks specificity [45].
In pigs, the infection with T. gondii also use to be asymptomatic, but in some cases, the active
infection or parasitemia reactivation could impact over reproductive parameters (abortions or
weak stillborns), mainly when is present in concomitance with other viral agents such as
parvovirus [46] or circovirus.
5. Molecular biology techniques for T. gondii detection
The diagnosis of toxoplasmosis is usually based on the detection of antibodies by ELISA
serology, agglutination assays or other methods such as Western blot immuno- or Sabin-
Feldman [47] staining. However, there are times when serological or with any of the afore‐
mentioned detection methods are not possible; in these cases the techniques of molecular
biology have been helpful in the diagnosis of T. gondii, especially the PCR technique, which
has proved to be a valuable tool [2,48].
Currently different strategies for molecular diagnosis of T. gondii have been developed; this
has meant that various methodologies are reported (both for the extraction of nucleic acids
and for the detection of different amplification targets) and brings about a large variation
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between results from different laboratories [49]. So the aim of this chapter is to review the main
methods of extraction, purification, detection and quantification of DNA from T. gondii in
different species intended for human consumption.
5.1. DNA extraction methods
The extraction and purification of nucleic acids is the first stage of most molecular biological
studies; extraction methods allow to obtain nucleic acids from various sources and then
perform specific analysis by polymerase chain reaction (PCR) or its variants [49]. The quality
and purity of the nucleic acids are two of the most important elements of such analysis since
contaminants can interfere by inhibiting the amplification process in which PCR [50] rests. This
makes clear that the importance of the process of sample preparation and DNA extraction
methodology used, to have significant impact on the sensitivity of the test [50,51].
To extract the nucleic acids of the biological material, samples must be homogenized, causing
cell lysis, proteins be removed by incubation with a protease and finally nucleic acids should
be separated from other cellular components [50]. The ideal lysis procedure, which usually
consists of a balancing techniques, must be strong enough to break the complex starting
material (a fabric, for example), but gentle enough to preserve the nucleic acids. The lysis
process is generally performed by physical or chemical processes, which break the bonds
between the cells to facilitate interaction with lysis solutions that help release the genetic
material [50, 51]. Among the conventional methods for extracting genetic material from T.
gondii in tissue include the following procedures previous to DNA extraction.
5.1.1. Mechanical homogenization with liquid nitrogen
This process involves macerating the sample with liquid nitrogen using a mortar to obtain a
fine powder. The nitrogen immediately can freeze the sample to prevent crystals formation,
thus avoiding the breakdown of cell structures and the start of DNA degradation process by
the action of DNase [51].
5.1.2. Chemical homogenization
In the chemical homogenization, the samples are maintained in solution at high temperatures
in the presence of proteases, detergents and chaotropic agents to break the bonds between the
cells or can even pierce the cell membrane. In fibrous tissue it is recommended that you cut
into small pieces to facilitate their decomposition. Before starting this type of homogenization
it is necessary to have information about the right amount of tissue; for rapid and complete
homogenization, it is necessary to ensure the recovery of DNA and prevent degradation [51].
5.1.3. Pepsin digestion
Pepsin digestion is a method developed by Jacos et al. in 1960 and is modified by Dubey (1998)
for retrieving from T. gondii from 50 g of muscle tissue (Dubey, 2010). The method is based on
the digestion process by which the parasite is released from tissue cysts to invade its host. In
this method, the homogenization of muscle tissue occurs by digestion with porcine pepsin
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solution, HCl, NaCl and distilled water at 37°C for 1 hour. Subsequently, a series of centrifu‐
gations allow the parasites to concentrate and be more likely to find their genetic material when
purification is performed. At the end of centrifugation the product has to be buffered with
bicarbonate to prevent degradation of the nucleic acids contained in the homogenate [22].
Pepsin requires acidic pH for activation; it breaks the bonds between tyrosine and phenylala‐
nine partially degraded proteins. Pepsin polypeptides of different sizes and some amino acids
are obtained without degrading completely, so this procedure is commonly followed by the
enzymatic action of another protease [52].
5.1.4. Proteinase K
Proteinase K is most often used because it is the widest-spectrum (degrades all proteins)
protease and it is often used with buffers containing SDS and EDTA [50]. Proteinase K is a
protease obtained from the fungus saprophyte Tritirachium album and is particularly suitable
for digestion in a short time. Proteinase k acts on the carboxyl group of amino acids and is
highly stable in a wide range of temperatures and pH values, having its greatest activity at
elevated temperatures [53].
5.2. DNA purification methods
The DNA purification methods can be classified into two major branches: traditional protocols
and by commercial kits [51].
5.2.1. Conventional protocols
They were developed in the 1950s; organic solvents used to separate proteins and DNA, once
suspended in the aqueous phase by ethanol precipitation isolate [51]. In the case of T. gondii,
more purification methodology used in the traditional methods is performed by phenol/
chloroform.
5.2.2. Phenol/chloroform
The phenol/chloroform purification is a method of liquid-liquid organic extraction consisting
of separate mixtures of molecules, which is based on the difference in solubility of individual
molecules in two different liquids [52,53]. The nucleic acid extraction with phenol/chloroform
involves adding equal volumes of phenol/chloroform aqueous cell lysate or tissue homoge‐
nate, mixing the two phases and allowing to separate by centrifugation (Alejos et al., 2014).
The phenol/chloroform method ensures the separation of liquids in two phases (organic and
aqueous lower than), because chloroform is miscible with phenol due to its higher density (1.47
g/cm3) phenol [54,55].
Nucleic acids are soluble in the upper aqueous phase because of their negatively charged
phosphate backbone, while proteins and lipids are separated in the organic phase [55]. Phenol
causes precipitation of proteins and polymers (including carbohydrates) that are contained in
the interface between the two phases (often as a white supernatant); in the case of lipids, these
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are dissolved in the lower organic phase. The separation between the aqueous and organic
phase by centrifugation allows isolation of the DNA in the aqueous phase (Karp, 2009; Soma,
2010). Subsequently the DNA is recovered from the aqueous phase with ethanol and is
insoluble, causing centrifugation to precipitate it [51].
5.3. DNA extraction using commercial kits
From the 1990s were introduced to market commercial purification kits; these kits commonly
used membranes or inorganic matrices to which the DNA will bind to specific conditions
(Karp, 2009). Often these arrays are stacked into small columns in centrifuge tubes so that the
binding steps, washing and elution can be performed efficiently by applying a centrifugal
force. Some of the advantages of using commercial kits are to increase efficiency of DNA
recovery, to obtain inhibitor-free extract and to decrease the time spent for purification {51,54]
The purification procedure with commercial kits can be summarized in three steps: 1)
homogenization of tissues to facilitate the selective attachment of DNA to the matrix; 2)
washing to remove DNA contaminants and 3) recovering the DNA from the matrix using an
eluting buffer [51].
Figure 1. DNA purification with phenol/chloroform [55].
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5.3.1. Silica matrix
This method is based in selectively adsorption/desorption of nucleic acids and it has proven
more efficient for the recovery of pure DNA beside biological samples (i.e., blood, tissue). Silica
extraction methods produce increased DNA yield while efficiently removing PCR inhibitors;
those protocols usually include a small-scale silica-based spin column. The selective adsorp‐
tion/desorption occurs when, by the action of ethanol, the DNA loses its humectant layer,
exposing its phosphate groups and thereby facilitating the adsorption of the molecule to the
positively charged membrane. Lipids and proteins are not related to the membrane and are
removed using the wash solution and a cycle of centrifugation, while the genetic material
remained is bound to the matrix [51].
5.3.2. Magnetic beads
Extraction methodology using magnetic beads or a magnet that attracts magnet to separate
the beads from solutions in which they are suspended is applicable. In this case, the lysis buffer
solution at acidic pH, which allows to positively charge the beads, favoring DNA binding
[51,53], is added.
The methodology for the extraction and purification of DNA from T. gondii in tissue with
magnetic beads was described by Opsteegh et al. [56]. Tissue homogenization is carried out in
a bag filter Stomacher400 containing a lysis buffer (100 mM Tris HCl pH 8.0, 5 mM EDTA pH
8.0, 0.2% SDS, 200mMNaCl and 40mg/L Proteinase k), by reaction using 2.5 mL of lysis buffer
per gram of sample for 2 minutes at high speed. The homogenate is placed in incubation at
55°C overnight and, after the incubation, the extract obtained is homogenized again for 1
minute; 50 mL of the homogenate is transferred to a 50-mL tube and is centrifuged at 3500 g
× 45 min; 12 mL of the supernatant (crude extract) is collected for use in the purification of the
genetic material of T. gondii.
The first step in the purification process based on magnetic beads is the removal of free biotin
in the sample because this method is based on the target binding sequence labeled with biotin
to the magnetic beads that are coated with streptavidin (protein high affinity for biotin). To
remove free biotin from the sample streptavidin sepharose should be added to allow the biotin
precipitation and to form a pellet by centrifuging and 10 mL of the supernatant are finally used
for purification process [56,57].
To mark the sequences of interest with biotin is needed the addition of specific primers that
are marked with this molecule [57]. The bonding occurs during hybridization, so it is first
necessary to denature the sample nucleic acids by heating at 95°C for 15 min and then lower
the temperature to allow hybridization; if the proposed protocol is by Opsteegh et al. [56]. the
hybridization temperature is 55°C for 45 min. Once labeled primers are hybridized to the target
sequence, we proceed to introduce the magnetic beads in the sample and proceed to incubate
at room temperature for 60 minutes to allow binding sequences labeled with magnetic beads.
They are separated from the beads using a magnet and then the DNA of the beads was
recovered by washing with buffer B & W (Binding & Washing) provided in the kit extraction
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and finally the DNA recovered is resuspended in distilled water. Magnetic capture process is
presented in Figure 2.
Figure 2. DNA purification from tissue employing magnetic beads [56].
Today there are also cases that implement business purification methods with organic solvents.
Usually these methods are based on the phenol/chloroform by adding guanidine or any other
part that improves the extraction and purification of nucleic acids. Examples of these tradi‐
tional methods are converted to commercial kits extraction and extraction with TRIzol®
DNAzol® [58,59]. These commercial kits based home methods are usually cheaper than
commercial kits based on inorganic matrices, although purification performance is very similar
in some cases, there is a risk of contamination of samples with phenol and inhibition of
amplification in the PCR process [60]. Another important factor to consider is security, since
this type of extraction involves the use of corrosive and irritant substances and therefore
requires some experience to handle; accidental contact with the reagents that can burn skin
and vapors inhalation could cause damage to the respiratory system, in both cases, medical
assistance is required. Table 1 presents the main commercial kits used for the extraction and
purification of DNA from T. gondii.
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Commercial kit Fundamental Column
material
Amount of recovered
DNA
Reference
Universal Genomic DNA
Extraction Kit (TaKaRa, USA)
Absorption/
desorption
Silica 10µg (2–30 mg of tissue) [61].
Easy-DNA®Kit (Invitrogen) Organic extraction N/A 150µg (50 mg of tissue)
5–10 ng/µL blood
[62].
High Pure PCR Template
Preparation Kit (Roche
Diagnostics, Mannheim
Germany)
Absorption/
desorption
Glass fiber
filter
3–9 µg (200–300 µL blood)
25–50 mg of tissue
(variable amount
recovered depending the
tissue tested)
[6].
[63].
QIAamp DNA Mini Kit
(QIAGEN, Valencia, CA)
Absorption/
desorption
Silica 4–12µg (200µL blood)
25–45µg (25mg of cardiac
tissue)
[21,47,64–68].
TRIzol® LS Reagent (Invitrogen,
Paisley, the United Kingdom)
(Fenol-Cloroformo)
Organic liquid-
liquid extraction
N/A 2–3µg (for each mg of
sample)
[69].
Phenol-Chloroform Organic liquid-
liquid extraction
N/A --- [70–76]
NucleoSpin Tissue Kit
(Macherey Nagel, Czech
Republic)
absorption/
desorption
Silica 20–35µg (25mg of tissue) [77].
Biotin labeled capture
oligonucleotides and
Streptavidin labeled magnetic
beads (Invitrogen)
magnetic capture Magnetic
beads
Recovered DNA from 5–
100pb
[5,47,56]
NucliSens easy MAG system
(BIOMERIEUX)
magnetic capture Magnetic
Silica
--- [49,78,79]
Genomic Prep Blood DNA
isolation kit (Amersham
Pharmacia
Biotech, the United Kingdom)
absorption/
desorption
Silica Recovered DNA from
100–200 kb
DNAzol® (Life technologies) organic extraction N/A 3–5µg/mg from tissue [80].
Qiaquick y PCR purification kit
(QIAGEN, Valencia)
absorption/
desorption
Silica 10 µg DNA recovered
from 100pb–10kb
[81,82]
DNeasy Blood & Tissue Kit
(QIAGEN)
absorption/
desorption
Silica 10–30ug (25mg of tissue) [83,84]
Table 1. Leading commercial kits used for DNA extraction and purification from different tissues for T. gondii
detection
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6. Methods for molecular detection of T. gondii in meat for consumption
The presence of T. gondii in biological samples can be diagnosed by molecular techniques
aimed at detecting its genetic material [74,85] (Switaj et al., 2005; Garcia et al., 2006). A specific
fragment of the parasite genome can be amplified by PCR to visualize on a polyacrylamide or
agarose gel, to stain, to sequence directly in real time. The sensitivity and specificity of PCR-
based techniques rely on an appropriate method of purification of genetic material from the
samples, the characteristics of the DNA sequences chosen for amplification and the parameters
of the amplification reaction [50,85]. Various amplification methods for T. gondii will be
explained below.
6.1. Conventional PCR (endpoint)
The PCR is a molecular biology technique developed by Dr. Kary B. Mullis in 1985 [54,86]. The
impact of his discovery was such that Dr. Mullis received the Nobel Prize for Chemistry in
1993 (Welch, 2012). PCR is a technique "in vitro" used to amplify enzymatically a specific region
of DNA located between two regions of DNA whose sequence is known [86]. PCR simulates
what happens during cell replication taking advantage of features of the chemical structure
and semiconservative DNA replication [50].
DNA is a polymer formed from two complementary strands anti-parallel, each chain consists
of nucleotide units which in turn are comprised of a nitrogenous base (adenine = A, guanine
= G, cytokine = C and thymine = T) attached to sugar deoxyribose and a triphosphate group
[50,87]. To replicate the DNA separates its two complementary strands, serving each mold or
template for the "de novo synthesis" of its complementary strand, the specificity of pairing of
the nitrogenated bases (TA, CG) to obtain two identical DNA molecules, each consisting of an
original and a new chain. The enzyme that performs this process is called DNA polymerase
[54,87]. PCR synthesis of new DNA strands is performed by mixing: containing DNA or
fragments to be amplified; polymerase; primers (DNA fragment of 15 to 30 nucleotides
flanking the region to be amplified and to provide the free 3 'end to initiate transcription);
deoxynucleotides (dNTPs); magnesium chloride (MgCl2) or other cofactor necessary to work
polymerase [86]. Generally, the PCR begins with denaturation or separation of the double helix
of DNA by heating the sample at a temperature between 94 and 96°C to break the hydrogen
bonds that bind them, so as each string is a template for synthesis A new complementary strand
of DNA [88].
Once separated the chains of DNA primers (initiators or primers) are aligned in complemen‐
tary-specific sites of the single strands in the region to be amplified; for this to happen it is
necessary to lower the temperature between 40 and 60°C, allowing binding (hybridization or
alignment) of the primers. Finally, a new strand is synthesized in the 5′ to 3′ for which the
temperature is increased, generally at 72°C, which is the optimum temperature to work Taq
polymerase [89]. These three stages — 1) denaturation, 2) hybridization and 3) elongation of
DNA — are repeated successively in each new cycle and amplified the region of interest of the
two complementary strands [86] simultaneously. The essential equipment for the process to
take place is the thermal cycler, which has a heating pad where each reaction is placed and
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where temperature changes are accurate and can be pre-programmed in three stages by several
cycles [50, 86].
Detecting the PCR product is usually accomplished by electrophoresis. Separation matrices
(agarose, polyacrylamide) at various concentrations are used depending on the size of the
amplification product and the resolution desired. The posterior viewing can be done with
ethidium bromide with a UV lamp, silver staining, fluorescence or radioactivity light. The sizes
of the PCR products are determined by comparing them with markers containing DNA
fragments of known size, which are run in a gel with PCR products.
6.2. Nested PCR
Nested PCR (nested) consists of two successive processes of amplification, using the product
of the first amplification as template for the second [2]. In the second amplification primers
used should be different from the first amplification and are targeted to amplify a smaller
fraction contained within the product of the first PCR [90]. This methodology increases both
the sensitivity and specificity of the test. Furthermore, the risk of contamination increases
significantly due to the increased amount of amplification products and work steps involved
[91]. In this type of test validation it is always recommended by both negative and positive
controls, ensuring that the positive controls are highly diluted to avoid contamination of the
samples [90].
6.3. PCR-LAMP
This is a variant of PCR developed for parasites of the phylum Apicomplexa, among which is
T. gondii. The amplification method LAMP (Loop-mediated isothermal amplification) is based
on a displacement auto cyclic reaction chain using a set of four oligonucleotides (primers)
which recognize six sequences within the genomic DNA target region and form a loop
structured amplicon, the polymerase that performs this function is Bst polymerase having
activity displacement [92,93].
6.4. Real-time PCR (qPCR)
Real-time PCR is a technique used to quantify specific nucleic acid sequences in a sample of
interest. The assay is based on generating a fluorescent signal that is directly proportional to
the amount of target DNA. Real-time PCR is able to monitor the fluorescence emission that
occurs during the reaction progress, so is said to be in real time [94]. Among the major
fluorophores used for determination of T. gondii load are as follows:
6.4.1. SYBR Green™
It is an intercalator that binds to dsDNA resulting fluorescence increased with increasing the
amount of PCR product. An important aspect to consider is that the SYBR Green™ can also
join primer dimers and nonspecific amplification products, resulting in an overestimation of
the concentration of target DNA. The detection of DNA of T. gondii using SYBR Green it could
be useful mainly during experimental infections. It has been used for monitoring parasitemia
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loads in animal models, however for clinical diagnosis or monitoring any other natural
infection (i.e., in animals for consumption) the performance it is not enough sensitive to detect
the presence of low amount of the target in the sample.
6.4.2. TaqMan™
TaqMan probes are hydrolysis probes which allow increase the specificity of quantitative PCR.
They have attached a reporter (a fluorophore) and a quencher. When both (fluorophore and
the quencher) are in proximity, the reporter emits no signal, however, when the probe
hybridizes to the sequence of interest during PCR, the endonuclease activity of Taq polymerase
to short photochromic other reporter probe, allowing emission of a fluorescent signal. The
reporter fluorescent signal is cumulative in each of the subsequent cycles [79].
7. Determination of parasite load in meat by qPCR
7.1. Absolute quantification
Absolute quantitation is a quantization strategy based on comparison of the test samples
against a standard curve created from a template of known concentration (Sivaganesan et al.,
2010). This template of known concentration is used to make serial dilutions and generate a
curve from the CT values (threshold cycle) obtained for each concentration. The curve can
interpolate directly the CT values of the test samples and get your concentration by the
equation Q =10( CT − bm ) where: Q = amount shown, CT = amplification cycle, b = insertion axis
"and" m = gradient of the line. In traditional protocols creating absolute quantification standard
curve in each qPCR experiment conducted it suggested, however, can also be employed master
calibration curve generated from multiple experiments qPCR [95]. The absolute quantification
method is conceptually easy, however, requires a reliable source as a template of known
concentration.
7.2. Relative quantification
Such quantification measures changes in the basal state of a gene of interest versus constant
gene expression that acts as a control. The difference lies in the absolute quantification that are
not part of a known amount of DNA, but an endogenous housekeeping gene control or
reference "housekeeping". Because the absolute amount of internal standard is unknown, can
be determined only relative changes of the gene of interest with reference to the endogenous
gene. Some of the most commonly used reference genes include glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), β-actin, hypoxanthine guanine phosphoribosyl transferase (HPRT)
and 18S ribosomal RNA.
The advantage of using mass units and normalizing the experimental design is that it is
conceptually simple, but requires accurate quantitation of starting material to be used as a
normalizer. There are some methods and models to determine the amount of DNA that are
based on comparison of the CT values using the efficiency of PCR reaction as a correction
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factor. However, there is also a model that does not require the reaction efficiency of accessing
a correction factor, assuming 100% efficiency in the PCR reaction in real time, both study gene
as reference gene, this Method 2 is delta-delta CT (2-ΔΔCT) (Vinuesa, 2009; Aguilera et al,
2014.). Method 2-ΔΔCT expresses the ratio obtained from the relationship between the CT
values of the sample and control values CT. Assay validation is made by serial dilution
problem for both the endogenous gene to gene. ΔCt values (CT gen – CT endogenous) are
obtained. These are plotted on the "y" axis versus the logarithm of the concentration in each
of the dilutions in the "x" axis. The slope of the line should be less than or equal to 0.1 so that
the method is valid [69]. Table 2 shows the most commonly used primers for the detection by
different variants of PCR and also are listed the ones used to estimate the parasite load of T.
gondii in tissues.
Amplification
target
primers Sequence
5′–3′
Amplicon
size
Reference
PCR endpoint
529pb Repeat
Element (RE)
Toxo4
Toxo5
CGCTGCAGGGAGGAAGACGAAAGTTG
CGCTGCAGACACAGTGCATCTCGGATT
529pb [62,74,75]
Gen B1 Tg1
Tg2
AAAAATGTGGGAATGAAAGAG
ACGAATCAACGGAACTGTAAT
469pb [3,21,64]
Gen B1 F
R
AGCCTCTCTCTTCAAGCAGCGTA
TCGGAGAGAGAAGTTCGTCGCAT
300pb [71,83]
Nested PCR
Gen B1 S1
AS1
S2
AS2
TGTTCTGTCCTATCGCAACG
ACGGATGCAGTTCCTTTCTG
TCTTCCCAGACGTGGATTTC
CTCGACAATACGCTGCTTGA
580 pb
530pb
[49]
Gen GRA6 GRA6-F1x
GRA6-R1
GRA6-F1
GRA6-R1x
ATTTGTGTTTCCGAGCAGGT
GCACCTTCGCTTGTGGTT
TTTCCGAGCAGGTGACCT
TCGCCGAAGAGTTGACATAG
546pb
351pb
[76]
Gen B1 B1F1
B1R1
B1F2
B1R2
TCAAGCAGCGTATTGTCGAG
CCGCAGCGACTTCTATCTCT
GGAACTGCATCCGTTCATGAG
TCTTTAAAGCGTTCGTGGTC
194pb [96]
529 pb RE REF1
RER1
REF2
RER2
TGACTCGGGCCCAGCTGCGT-3′
CTCCTCCCTTCGTCCAAGCCTCC-3′
AGGGACAGAAGTCGAAGGGG-3′
GCAGCCAAGCCGGAAACATC-3′
164pb [93,96]
PCR LAMP
529bp RE F3
B3
FIP (F1 c-F2)
BIP (B1c-B2)
ACGAGAGTCGGAGAGGGA
TGGATTCCTCTCCTACCCCT
GGATCGCATTCCGGTGTCTCTTAAGATGTTTCCGGCT
TGGC
202pb [93, 96]
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Amplification
target
primers Sequence
5′–3′
Amplicon
size
Reference
GACGACGCTTTCCTCGTGGTCAAGCCTCCGACTCTGT
CT
529bp RE F3
B3
FIP
BIP
LF
LB
CCACAGAAGGGACAGAAGTC
TCCGGTGTCTCTTTTTCCAC
TCCTCACCCTCGCCTTCATCTAGGACTACAGACGCGA
TGC
TGGTTGGGAAGCGACGAGAGTTCCAGGAAAAGCAG
CCAAG
TCCAAGACGGCTGGAGGAG
CGGAGAGGGAGAAGATGTTTCC
202pb [96,97]
Gen B1 BIP
FIP
F3
B3
TCGCAACGGAGTTCTTCCCAGTTTTGGCCTGATATTA
CGACGGAC
TGACGCCTTTAGCACATCTGGT
TTTTGATGCTCAAAGTCGACCGC
GGGAGCAAGAGTTGGGACTA
CAGACAGCGAACAGAACAGA
212 pb [96]
qPCR
Gen B1 SYBR
Green™
BE-F: CTCCTTCGTCCGTCGTAATATC
BE-R: TGGTGTACTGCGAAAATGAATC
451pb [47]
SAG 1 SYBR
Green™
F: CTGATGTCGTTCTTGCGATGTGGC
R: GTGAAGTG-GTTCTCCGTCGGTGT
128pb [61]
Gen B1 SYBR
Green™
F: CGTCCGTCGTAATATCAG
R: GACTTCATGGGACGATATG
98pb [47]
529pb RE TaqMan™ F: CACAGAAGGGACAGAAGT
R: TCGCCTTCATCTACAGTC
RE probe: (JOEe)-CTCTCCTCCAAGACGGCTGG-
(TAMRAf)
94pb [47,63,69]
Gen B1 TaqMan™ GENE_B1_TG-TX2F: CTAGTATCGTGCGGCAATGTG
GENE_B1_TG-TX2R: GGCAGCGTCTCTTCCTCTTTT
GENE_B1_TG-TX2M1: 6-FAM)-CCACCTCGCCTCTTGG-
(NFQ-MGB)
62 pb [79]
Gen B1 TaqMan™ BE-F: CCCCACAAGACGGCTGABE-R:
TGGTGTACTGCGAAAATGAATC
TaqMan probe: (6-FAM)-
CATTTGCAAAACAGCGGCAGCGTCT-(DQ)
248pb [47]
529pb RE TaqMan™ TOX-9F: AGGAGAGATA TCAGGACTGT AG
TOX-11R: GCGTCGTCTC GTCTAGATCG
TOX-TP1: (6-FAM)-CCGGCTTGGC TGCTTTTCCT-(BHQ1)
524pb [5,47,56,77]
Table 2. Amplification targets, primers and probes used in the diagnosis and quantification of T. gondii in meat.
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Although there are several methods for the diagnosis of toxoplasmosis, the present work
focused on the most used by researchers working with T. gondii in animal tissue samples. In
this aspect the molecular, especially the PCR technique and its variants, has been a major
technique for diagnosing the presence and in some cases abundance of the parasite in the
tissues of the various productive species that are commonly consumed tool.
The sensitivity of PCR techniques is influenced by several factors, among which are tissue
type, sample handling, the process employed in the extraction and purification of nucleic
acids and the type of card selected amplification. All these factors cause variation sensitivi‐
ty in these tests of about 20% to over 80% in some cases. Variations of the PCR most commonly
used for the diagnosis of toxoplasmosis are conventional PCR, LAMP-PCR, nested PCR and
real time PCR, considered as the most sensitive nested PCR and PCR techniques in real time,
can detect the presence of nucleic acids of T. gondii from a single parasite in the sample.
The techniques of DNA extraction and purification significantly affect the development of
PCR  techniques;  the  presence  of  contaminants  may  inhibit  the  amplification  process.
Nowadays, there are different methodologies used for DNA extraction and also, there is a
wide variety of  commercial  options available to perform the procedures,  however,  even
almost all of them have been designed to obtain as much amount of DNA as possible from
any  specimen  while  minimizing  manual  handling  and  co-extraction  of  PCR  inhibitors.
Methodologies based in small-scale silica-based spin column, has proven more efficient for
the recovery of pure DNA in comparison with phenol/chloroform extraction, because they
have showed several disadvantages besides being unable to remove potential PCR inhibi‐
tors efficiently.
The sensitivity of PCR assays depends heavily on the number of copies of the target sequence;
in the case of T. gondii although various cards amplification as is the case of SAG1, SAG2,
SAG3 and GRA6 genes, most widely used are those which are directed to highly repetitive
genes as gene B1 is repeated 35 times in the genome of T. gondii or repeated 529pb frac‐
tion, which is repeated 200 to 300 times in the parasite genome. Although the B1 gene is
considered to be the gene of choice for the diagnosis, repeated fraction 529pb has begun to
have a greater impact due to it being repeated more times increases the sensitivity of PCR
testing. This trend toward the use of these cards amplification is observed in most variants
of the PCR.
An important aspect for the selection of the PCR technique used in the diagnosis of toxoplas‐
mosis has been the cost involved, the techniques of real-time PCR are usually much more
expensive due to the use of probes and specialized equipment for reading the results, so this
type of quantitative PCR are mainly used for research.
It is important to consider that molecular methods allow us to estimate whether the presence
(when we use some variants as endpoint PCR or nested PCR) or quantity (by qPCR) parasite
DNA in the evaluated sample.  However,  these findings do not  allow for  determination
whether the parasites are viable and capable of producing infection.
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Tissues that tend to have higher parasite loads are often brain, heart and spleen, but it is
feasible to detect the presence of the parasite in other tissues intended for human consump‐
tion. Loading and distribution of parasites depends on biotype and density involved in the
environment, as well as the animal's age and the type of production system. Due to this high
variability, it is important to determine which tissues have higher loads and biotypes which
are involved in order to avoid risks of transmission to consumers of meat from different
regions and emphasize the importance of giving proper management to meat products (such
as cooking or freeze) to reduce the risk of acquiring infection by eating them.
8. Conclusion and recommendation
Toxoplasmosis is a zoonotic disease transmitted by common foods; the occurrence of cysts of
T. gondii in meat for human consumption represents a potential health risk, especially if the
meat is consumed raw or cooked at lower temperatures of 67°C. In this sense the existence of
accurate and reliable diagnostic tests is essential for the detection, monitoring and control of
infections in intermediate hosts and to minimize the risk of infection in humans.
For the diagnosis of infection in tissue samples from naturally infected animals intended for
consumption, it is desirable to use the technique Taqman qPCR probes since it is a more
sensitive alternative to the same qPCR detection when used with SYBR Green dye. The format
for performance this technique (qPCR with a Taqman probe) is versatile, allowing to evaluate
both few samples (in a research environment for example) and in environments where it is
required to test a greater number of specimens in a short time period (i.e., specialized labora‐
tories for monitoring food safety), and increasingly, inputs for this procedure are more
affordable.
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